Titan Medical TMDI
$ 0.14
-26.32%
Annual report 2020
added 08-19-2023
Titan Medical Balance Sheet 2011-2024 | TMDI
Annual Balance Sheet Titan Medical
2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
---|---|---|---|---|---|---|---|---|---|---|---|
Net Debt |
-31 M | - | -785 K | - | - | -128 K | -418 K | -549 K | -260 K | -160 K | -9.54 M |
Long Term Debt |
981 K | - | 8 K | - | - | - | - | - | - | - | - |
Long Term Debt Current |
346 K | 166 K | 21.1 K | - | - | - | - | - | - | - | - |
Total Non Current Liabilities |
- | 751 K | 8 K | - | - | - | - | - | - | - | - |
Total Current Liabilities |
- | - | - | - | - | - | - | - | - | - | - |
Total Liabilities |
11.9 M | 43.6 M | 15.1 M | 17.7 M | 20.1 M | 6.6 M | 13.3 M | - | 1.19 M | 1.11 M | 1.97 M |
Deferred Revenue |
- | - | - | - | - | - | - | - | - | - | - |
Retained Earnings |
-254 M | -239 M | -215 M | -173 M | -150 M | -116 M | -89.3 M | - | -30.6 M | -24.2 M | -23.4 M |
Total Assets |
47.2 M | 29.8 M | 3.38 M | 21.9 M | 29.7 M | 7.19 M | 12.9 M | - | 3.21 M | 5.77 M | 11.1 M |
Cash and Cash Equivalents |
32.3 M | 25.5 M | 814 K | 11.5 M | 26.1 M | 4.34 M | - | - | - | - | - |
Book Value |
35.3 M | -13.8 M | -11.7 M | 4.22 M | 9.61 M | 595 K | -411 K | - | 2.02 M | 4.66 M | 9.15 M |
Total Shareholders Equity |
35.3 M | -13.8 M | -11.7 M | 4.22 M | 9.61 M | 595 K | - | - | - | - | - |
All numbers in USD currency
Quarterly Balance Sheet Titan Medical
2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Long Term Debt |
- | - | - | 890 K | 981 K | 1.07 M | 1.02 M | 704 K | 751 K | 347 K | 367 K | - | 8 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Non Current Liabilities |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Liabilities |
- | - | - | 8.86 M | 11.9 M | 24.6 M | 28.1 M | 29.6 M | 43.6 M | 24.5 M | 30.3 M | - | 15.1 M | 22.6 M | 39.5 M | - | 17.7 M | - | - | - | 20.1 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Deferred Revenue |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Retained Earnings |
- | - | - | -263 M | -254 M | -263 M | -255 M | -254 M | -239 M | -218 M | -217 M | - | -215 M | -217 M | -216 M | - | -173 M | - | - | - | -150 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Assets |
- | - | - | 35.5 M | 47.2 M | 50.1 M | 60.4 M | 58.8 M | 29.8 M | 28.2 M | 32.3 M | - | 3.38 M | 5.73 M | 21.2 M | - | 21.9 M | - | - | - | 29.7 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Cash and Cash Equivalents |
- | - | - | 30.1 M | 32.3 M | 44.7 M | 55 M | 53.4 M | 25.5 M | 24.7 M | 28.7 M | 1.76 M | 814 K | 10.3 M | 23.6 M | 23.6 M | 11.5 M | 29.2 M | 22.4 M | 20.5 M | 26.1 M | - | - | - | 4.34 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Book Value |
- | - | - | 26.7 M | 35.3 M | 25.4 M | 32.2 M | 29.2 M | -13.8 M | 3.72 M | 2.08 M | - | -11.7 M | -16.9 M | -18.3 M | - | 4.22 M | - | - | - | 9.61 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Shareholders Equity |
- | - | - | 26.7 M | 35.3 M | 25.4 M | 32.2 M | 29.4 M | -13.8 M | 3.72 M | 2.08 M | -8.39 M | -11.7 M | -16.9 M | -18.3 M | - | 4.22 M | 12 M | 7.38 M | - | 9.61 M | - | - | - | 595 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency